AP Biosciences Inc.
AP Biosciences Inc.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors | Solid Tumours | Recruiting | Phase 1 | 2025-12-29 | NCT07165067 | |
| A Study of AP402 in HER2-Positive Patients With Locally or Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2025-04-25 | NCT06669975 | |
| A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Phase 1 / Phase 2 | 2025-03-26 | NCT05473156 | |
| A Study of AP505 Injection in Patients With Advanced Malignant Solid Tumors | Advanced Solid Tumors | Active, not recruiting | Phase 1 | 2024-12-09 | NCT06723964 |